Development and Maintenance of Human and Animal Food Rapid Response Teams (U2F) Clinical Trials Not Allowed
The summary for the Development and Maintenance of Human and Animal Food Rapid Response Teams (U2F) Clinical Trials Not Allowed grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Food and Drug Administration, which is the U.S. government agency offering this grant.
Development and Maintenance of Human and Animal Food Rapid Response Teams (U2F) Clinical Trials Not Allowed: The purpose of this FOA is to develop and maintain Rapid Response Teams (RRTs) to facilitate long-term improvements and innovation to the national integrated food safety system by unifying and coordinating federal/state/local human and animal food (HAF) emergency response efforts including:1) Strengthening the link among epidemiology, lab and environmental health/regulatory components;2) Improving States' regulatory and surveillance HAF protection programs to include using Incident Command System (ICS)/National Incident Management System (NIMS) principles and a Unified Command structure to conduct integrated responses to all-hazards HAF emergencies, rapidly identifying and removing tainted food from commerce, and conducting root cause investigations to inform future prevention efforts; and3) Addressing supporting components, such as training, data sharing, data analysis, communications, continuous process improvement, and development of best practices and other resources to support national response capacity/capability development.
Federal Grant Title: | Development and Maintenance of Human and Animal Food Rapid Response Teams (U2F) Clinical Trials Not Allowed |
Federal Agency Name: | Food and Drug Administration (HHS-FDA) |
Grant Categories: | Agriculture Consumer Protection Food and Nutrition |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-FD-23-019 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.103 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | April 14th, 2023 |
Original Application Deadline: | April 14th, 2023 |
Posted Date: | February 2nd, 2023 |
Creation Date: | February 2nd, 2023 |
Archive Date: | May 14th, 2023 |
Total Program Funding: | |
Maximum Federal Grant Award: | $360,000 |
Minimum Federal Grant Award: | |
Expected Number of Awards: | 25 |
Cost Sharing or Matching: | No |
Last Updated: | February 2nd, 2023 |
- Applicants Eligible for this Grant
- State governments
- Link to Full Grant Announcement
- Full Annoucement
- Grant Announcement Contact
- Janelle Fundersburg
Grantor
Phone 301-798-2533
[email protected] - Similar Government Grants
- • Convener and Organizer of Activities and Engagements Related to Processes, Surveillance, a...
- • Development and Maintenance of the Animal Food Regulatory Program Standards (U19) Clinical...
- • Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biologic...
- • Cooperative Agreement to Support the World Trade Organization's (WTO) Standards and Trade ...
- • Cooperative Agreement for Long Term Data Collection on Antimicrobial Use in Animals (U01) ...
- • Support for Small Scientific Conference Grant Program
- • Cooperative Agreement to Support the World Health Organization (WHO) International Program...
- • Clinical Studies of Safety and Effectiveness of Orphan Products
- More Grants from the Food and Drug Administration
- • Convener and Organizer of Activities and Engagements Related to Processes, Surveillance, a...
- • Development and Maintenance of the Animal Food Regulatory Program Standards (U19) Clinical...
- • Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biologic...